JP2024540642A5 - - Google Patents
Info
- Publication number
- JP2024540642A5 JP2024540642A5 JP2024530488A JP2024530488A JP2024540642A5 JP 2024540642 A5 JP2024540642 A5 JP 2024540642A5 JP 2024530488 A JP2024530488 A JP 2024530488A JP 2024530488 A JP2024530488 A JP 2024530488A JP 2024540642 A5 JP2024540642 A5 JP 2024540642A5
- Authority
- JP
- Japan
- Prior art keywords
- heterocycloalkyl
- alkyl
- cycloalkyl
- caution
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163282614P | 2021-11-23 | 2021-11-23 | |
| US63/282,614 | 2021-11-23 | ||
| US202263406215P | 2022-09-13 | 2022-09-13 | |
| US63/406,215 | 2022-09-13 | ||
| PCT/US2022/050777 WO2023096928A1 (en) | 2021-11-23 | 2022-11-22 | Hetero-atom containing compounds and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540642A JP2024540642A (ja) | 2024-10-31 |
| JP2024540642A5 true JP2024540642A5 (enExample) | 2025-12-01 |
Family
ID=86540280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024530488A Pending JP2024540642A (ja) | 2021-11-23 | 2022-11-22 | ヘテロ原子含有化合物及びその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240398828A1 (enExample) |
| EP (1) | EP4436967A4 (enExample) |
| JP (1) | JP2024540642A (enExample) |
| KR (1) | KR20240126446A (enExample) |
| AU (1) | AU2022397239A1 (enExample) |
| CA (1) | CA3238771A1 (enExample) |
| CL (1) | CL2024001543A1 (enExample) |
| CO (1) | CO2024007220A2 (enExample) |
| EC (1) | ECSP24047821A (enExample) |
| IL (1) | IL313028A (enExample) |
| MX (1) | MX2024006243A (enExample) |
| PE (2) | PE20251600A1 (enExample) |
| WO (1) | WO2023096928A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3238771A1 (en) * | 2021-11-23 | 2023-06-01 | Liansheng Li | Hetero-atom containing compounds and uses thereof |
| WO2024243441A1 (en) * | 2023-05-24 | 2024-11-28 | Kumquat Biosciences Inc. | Heterocyclic compounds and uses thereof |
| TW202519514A (zh) | 2023-07-14 | 2025-05-16 | 天主教魯汶大學 | 新穎化合物(一) |
| CN119707953B (zh) * | 2024-04-19 | 2026-07-31 | 中国药科大学 | 噻二唑烷酮衍生物及其制备方法和应用 |
| CN119707952B (zh) * | 2024-04-19 | 2026-05-26 | 中国药科大学 | 具有ptpn2/ptpn1抑制活性的噻二唑烷酮衍生物及其制备方法和应用 |
| WO2026112353A1 (en) * | 2024-11-22 | 2026-05-28 | Kumquat Biosciences Inc. | Heterocyclic compounds and uses thereof |
| WO2026112354A1 (en) * | 2024-11-22 | 2026-05-28 | Kumquat Biosciences Inc. | Heterocyclic compounds and uses thereof |
| WO2026112355A1 (en) * | 2024-11-22 | 2026-05-28 | Kumquat Biosciences Inc. | Heterocyclic compounds and uses thereof |
| WO2026110102A1 (en) * | 2024-11-22 | 2026-05-28 | iTeos Belgium SA | Protein tyrosine phosphatase inhibitors and methods of use thereof |
| WO2026112350A1 (en) * | 2024-11-22 | 2026-05-28 | Kumquat Biosciences Inc. | Heterocyclic compounds and uses thereof |
| WO2026133154A1 (en) * | 2024-12-18 | 2026-06-25 | Novartis Ag | Sodium channel blockers |
| WO2026132148A1 (en) | 2024-12-19 | 2026-06-25 | Katholieke Universiteit Leuven | Inhibitors of ptpn2/ptpn1 tyrosine phosphatase |
| WO2026132149A1 (en) | 2024-12-19 | 2026-06-25 | Katholieke Universiteit Leuven | Inhibitors of ptpn2 and/or ptpn1 |
| WO2026132150A1 (en) | 2024-12-19 | 2026-06-25 | Katholieke Universiteit Leuven | Inhibitors of ptpn 2/ ptpn1 tyrosine phosphatase |
| WO2026132146A1 (en) | 2024-12-19 | 2026-06-25 | Katholieke Universiteit Leuven | Inhibitors of ptpn 2/ ptpn1 tyrosine phosphatase |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0225986D0 (en) * | 2002-11-07 | 2002-12-11 | Astrazeneca Ab | Chemical compounds |
| RU2008127253A (ru) * | 2005-12-08 | 2010-01-20 | Новартис АГ (CH) | 1,1,3-триоксо-1,2,5-тиадиазолидины и их применение в качестве ингибиторов птфаз |
| JP2009532379A (ja) * | 2006-03-31 | 2009-09-10 | ノバルティス アクチエンゲゼルシャフト | ＰＴＰａｓｅのチアジアゾリジノン阻害剤 |
| WO2008067527A1 (en) * | 2006-12-01 | 2008-06-05 | Novartis Ag | Inhibitors of protein tyrosine phosphatase for the treatment of muscle atrophy and related disorders |
| BRPI0819703A2 (pt) * | 2007-11-30 | 2015-06-16 | Novartis Ag | Uso de inibidores de proteína tirosina fosfatase e hormônio de crescimento humano, uso de igf1 e um inibidor de proteína tirosina fosfatase e composição de combinação farmacêutica para o tratamento de atrofia muscular e distúrbios relacionados |
| US9977024B2 (en) * | 2012-12-09 | 2018-05-22 | The Scripps Research Institute | Targeted covalent probes and inhibitors of proteins containing redox-sensitive cysteines |
| SG11202108452WA (en) * | 2019-02-04 | 2021-09-29 | Ksq Therapeutics Inc | Combination gene targets for improved immunotherapy |
| CA3238771A1 (en) * | 2021-11-23 | 2023-06-01 | Liansheng Li | Hetero-atom containing compounds and uses thereof |
-
2022
- 2022-11-22 CA CA3238771A patent/CA3238771A1/en active Pending
- 2022-11-22 WO PCT/US2022/050777 patent/WO2023096928A1/en not_active Ceased
- 2022-11-22 MX MX2024006243A patent/MX2024006243A/es unknown
- 2022-11-22 KR KR1020247020608A patent/KR20240126446A/ko active Pending
- 2022-11-22 AU AU2022397239A patent/AU2022397239A1/en active Pending
- 2022-11-22 PE PE2025000777A patent/PE20251600A1/es unknown
- 2022-11-22 JP JP2024530488A patent/JP2024540642A/ja active Pending
- 2022-11-22 IL IL313028A patent/IL313028A/en unknown
- 2022-11-22 EP EP22899354.9A patent/EP4436967A4/en active Pending
- 2022-11-22 PE PE2024001137A patent/PE20241474A1/es unknown
-
2024
- 2024-05-20 US US18/669,349 patent/US20240398828A1/en active Pending
- 2024-05-22 CL CL2024001543A patent/CL2024001543A1/es unknown
- 2024-06-07 CO CONC2024/0007220A patent/CO2024007220A2/es unknown
- 2024-06-20 EC ECSENADI202447821A patent/ECSP24047821A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240083968A1 (en) | Treatment of cancer using chimeric cd3 receptor proteins | |
| US12617849B2 (en) | Antigen specific CD19-targeted CAR-T cells | |
| US20200360431A1 (en) | Bcma-targeting chimeric antigen receptor, cd19-targeting chimeric antigen receptor, and combination therapies | |
| CA3083949A1 (en) | Bcma-targeting chimeric antigen receptor, and uses thereof | |
| JP7118887B2 (ja) | 最適化されたレンチウイルス移入ベクターおよびその使用 | |
| US20190375815A1 (en) | Treatment of cancer using chimeric t cell receptor proteins having multiple specificities | |
| US12065474B2 (en) | Chimeric antigen receptors with mutated CD28 costimulatory domains | |
| IL295604A (en) | Methods of making chimeric antigen receptor-expressing cells | |
| KR20230058427A (ko) | Car 발현 세포의 생체내 생성을 위한 조성물 및 방법 | |
| US12037394B2 (en) | Compositions and methods for targeting CD33-expressing cancers | |
| JP2018527008A5 (enExample) | ||
| JP2020513828A5 (enExample) | ||
| JP2023138960A (ja) | キメラ抗原受容体を発現する免疫細胞 | |
| IL316970A (en) | Combination therapies of chimeric antigen receptors and PD-1 inhibitors | |
| JP2017513818A5 (enExample) | ||
| CN112040957A (zh) | 靶向表达cd99的癌症的组合物和方法 | |
| JP2024536840A (ja) | Ｉｌ－２バリアント及びその融合タンパク質 | |
| US20190374579A1 (en) | Tim3-binding chimeric antigen receptors | |
| US20250313622A1 (en) | Chimeric antigen receptor (car) constructs with nk receptor signaling domain | |
| US20190276555A1 (en) | Tag-72-binding chimeric antigen receptors | |
| US20250302878A1 (en) | Nkg2d expressing car-t cells | |
| WO2024196798A1 (en) | Fusion protein and uses thereof | |
| WO2026039641A1 (en) | Trp-1 binding antibodies and chimeric antigen receptors for targeting melanoma | |
| US20210177903A1 (en) | Car t-cells for the treatment of bone metastatic cancer | |
| WO2023220631A2 (en) | Selective k-ras inhibitors for the enhancement of adoptive immunotherapies |